These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38878808)
61. Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men. Schwarting A; Relle M; Meineck M; Föhr B; Triantafyllias K; Weinmann A; Roth W; Weinmann-Menke J Lupus; 2018 Feb; 27(2):243-256. PubMed ID: 28659046 [TBL] [Abstract][Full Text] [Related]
62. [Cytokines and adhesion molecules in renal vasculitis and lupus nephritis]. Tesar V; Masek Z; Rychlík I; Merta M; Bartůnková J; Stejskalová A; Zabka J; Fucíková T; Dostál C; Becvár R Cas Lek Cesk; 1997 Aug; 136(16):501-6. PubMed ID: 9441008 [TBL] [Abstract][Full Text] [Related]
63. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Pahl MV; Gollapudi S; Sepassi L; Gollapudi P; Elahimehr R; Vaziri ND Nephrol Dial Transplant; 2010 Jan; 25(1):205-12. PubMed ID: 19684120 [TBL] [Abstract][Full Text] [Related]
64. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis. Xia LP; Li BF; Shen H; Lu J Scand J Rheumatol; 2015 May; 44(3):200-5. PubMed ID: 25562331 [TBL] [Abstract][Full Text] [Related]
65. Characterization of Serum Cytokine Profiles of Patients with Active Lupus Nephritis. Rahmé Z; Franco C; Cruciani C; Pettorossi F; Zaramella A; Realdon S; Iaccarino L; Frontini G; Moroni G; Doria A; Ghirardello A; Gatto M Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834330 [TBL] [Abstract][Full Text] [Related]
66. Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis. Calvani N; Richards HB; Tucci M; Pannarale G; Silvestris F Clin Exp Immunol; 2004 Oct; 138(1):171-8. PubMed ID: 15373921 [TBL] [Abstract][Full Text] [Related]
67. Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease. Cotugno N; Finocchi A; Cagigi A; Di Matteo G; Chiriaco M; Di Cesare S; Rossi P; Aiuti A; Palma P; Douagi I J Allergy Clin Immunol; 2015 Mar; 135(3):753-61.e2. PubMed ID: 25175493 [TBL] [Abstract][Full Text] [Related]
68. [Distribution of interleukin-6 receptors (CD(126) and CD(w130)) on circulating lymphocytes in patients with lupus nephritis]. Zeng L; Sun L; Ye R; Xu H; Yu X; Kong Q; Zhou F Zhonghua Nei Ke Za Zhi; 2000 Sep; 39(9):603-6. PubMed ID: 11798527 [TBL] [Abstract][Full Text] [Related]
69. Pathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalities. Yap DY; Lai KN Int J Mol Sci; 2015 Apr; 16(4):7917-31. PubMed ID: 25860947 [TBL] [Abstract][Full Text] [Related]
70. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression. Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458 [TBL] [Abstract][Full Text] [Related]
71. [Effects of langchuangping granule on the expression of B lymphocyte activating factor in the peripheral blood B cells of BXSB lupus nephritis mice]. Li GY; Liu SX; Lu XQ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Mar; 32(3):367-70. PubMed ID: 22686085 [TBL] [Abstract][Full Text] [Related]
72. Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis. Nakano S; Morimoto S; Suzuki J; Mitsuo A; Nakiri Y; Katagiri A; Nozawa K; Amano H; Tokano Y; Hashimoto H; Takasaki Y Autoimmunity; 2007 Feb; 40(1):9-15. PubMed ID: 17364492 [TBL] [Abstract][Full Text] [Related]
73. Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai. Yadav S; Balakrishnan C; Mangat G; Kothari J Lupus; 2024 Jan; 33(1):88-95. PubMed ID: 38048588 [TBL] [Abstract][Full Text] [Related]
74. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages. Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C Front Immunol; 2020; 11():671. PubMed ID: 32351512 [TBL] [Abstract][Full Text] [Related]
75. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease. Greinix HT; Pohlreich D; Kouba M; Körmöczi U; Lohmann I; Feldmann K; Zielinski C; Pickl WF Biol Blood Marrow Transplant; 2008 Feb; 14(2):208-19. PubMed ID: 18215781 [TBL] [Abstract][Full Text] [Related]
77. Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. Satoh-Kanda Y; Nakayamada S; Kubo S; Yamagata K; Nawata A; Tanaka H; Kosaka S; Kanda R; Yu S; Fujita Y; Sonomoto K; Tanaka Y RMD Open; 2024 Jun; 10(2):. PubMed ID: 38871479 [TBL] [Abstract][Full Text] [Related]
78. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128 [TBL] [Abstract][Full Text] [Related]
79. Altered B lymphocyte homeostasis and functions in systemic sclerosis. Forestier A; Guerrier T; Jouvray M; Giovannelli J; Lefèvre G; Sobanski V; Hauspie C; Hachulla E; Hatron PY; Zéphir H; Vermersch P; Labalette M; Launay D; Dubucquoi S Autoimmun Rev; 2018 Mar; 17(3):244-255. PubMed ID: 29343447 [TBL] [Abstract][Full Text] [Related]
80. Immune cells and type 1 IFN in urine of SLE patients correlate with immunopathology in the kidney. Scott E; Dooley MA; Vilen BJ; Clarke SH Clin Immunol; 2016 Jul; 168():16-24. PubMed ID: 27102764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]